Promising antibody cocktail takes on Ebola virus—and its deadly cousin
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
5 takeaways from February's "Live from the Lab" webinar
Most coronaviruses usually cause the common cold, but, as happened with the SARS virus in 2003 and the MERS virus
They help us digest food, balance our immune system, and keep our hearts and brains healthy. But harmful viruses and
During the last week of August, the trucks finally started to arrive. Carefully nestled inside 22 huge wooden crates was
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) is honored to announce that Dr. Erica Ollmann Saphire, one of the